Is NCT00571389 recruiting in Huntersville, NC?

Yes, NCT00571389 is currently recruiting participants at its Huntersville, NC location. This solid tumor, adult clinical trial is actively enrolling qualified participants.

How do I join the solid tumor, adult clinical trial in Huntersville?

To join this clinical trial in Huntersville, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Huntersville clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Solid Tumor, Adult Clinical Trial in Huntersville, NC

About This Solid Tumor, Adult Study in Huntersville

Primary Objective: This is a study to investigate the feasibility of harvesting, expanding, and selecting T lymphocytes from cancer patients and healthy volunteers. The preliminary objective of this study is aimed at selecting PD-1+ and CTLA4+ T cells and other cellular fractions from peripheral blood of cancer patients and healthy volunteers by using specific conjugated antibodies, evaluating their functional ex vivo anti-tumor cytotoxicity against targeted autologous tumor cells.

Sponsor: BioCytics, Inc.

Who Can Participate

Inclusion Criteria

for Biospecimen(s) collection: Cancer Cohort Inclusion Criteria:

Male or Female Adult ≥ 18 years of age.

Histological diagnosis of any solid tumor type and at any stage of disease progression including in the neoadjuvant/presurgical setting, adjuvant setting, or considered in remission.

Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 to 3 (see Appendix 2) and an estimated life expectancy of at least 3 months.

Subject or subject's legal representative provides written informed consent.

Negative serology screening test for HIV, Hepatitis B surface antigen, and Hepatitis C antibody, or negative reflex PCR test result for HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)

Additional eligibility criteria need to be met for leukapheresis collection:

ECOG Performance Status of 0 or 1 (see Appendix 2)

WBC ≥2000/μL

Neutrophils ≥1000/μL

Platelets ≥100x103/μL

Hemoglobin ≥9 g/dL

Creatinine ≤2.5 x ULN

AST ≤2.5 x ULN without, and ≤ 5 x ULN with hepatic metastases

Bilirubin ≤2 x ULN (except patients with Gilbert's syndrome, who must have total bilirubin ≤ 3.0 mg/dL)

Negative urine pregnancy test for women of childbearing potential Healthy Volunteer Cohort Inclusion Criteria:

Male or Female Adult ≥ 18 years of age. ▪ Pediatric healthy volunteers from 5-17 years of age, with suspected or confirmed COVID-19 diagnosis by laboratory test will be eligible to participate in minimally invasive biospecimen collection procedures, as long as written parental consent has been obtained, and if applicable and technologically able, child assent. Minimally invasive biospecimen collection procedures allowed for pediatric participation include swabs (nasal, NP and OP), microcapillary sampling, and saliva or urine collection.

Healthy volunteers are eligible, including the following:

History of autoimmune disease or inflammatory disorder considered clinically stable by the Principal Investigator or treating physician's discretion.

Suspected or diagnosed COVID-19 disease by laboratory test, whether in the acute, sub-acute or convalesced state.

Employees of the study site(s) or BioCytics, as long as fulfilment of inclusion criteria 3.c is obtained.

Subject or subject's legal representative provides written informed consent.

Negative serology screening test for HIV, Hepatitis B surface antigen, and Hepatitis C antibody, or negative reflex PCR test result for HIV, HBV, and HCV.

Additional eligibility criteria need to be met for leukapheresis collection:

Must be ≥ 18 years of age.

WBC ≥2000/μL

Neutrophils ≥1000/μL

Platelets ≥100x103/μL

Hemoglobin ≥9 g/dL

Creatinine ≤2.5 x ULN

AST ≤2.5 x ULN

Bilirubin ≤2 x ULN (except patients with Gilbert's syndrome, who must have total bilirubin ≤ 3.0 mg/dL)

Negative urine pregnancy test for women of childbearing potential 2.3.4.

Exclusion Criteria

Subjects with active infection requiring therapy (fever, localizing source) will be excluded until the infection resolves. a. This excludes subjects with suspected or confirmed COVID-19 by laboratory test while in the acute and sub-acute phase of viremia.

Underlying medical condition that, in the Principal Investigator's or treating oncologist's opinion, will obscure the interpretation of the patient's safety.

Confirmed positive reflex PCR test result for HIV, Hepatitis B Virus (HBV), or Hepatitis C Virus (HCV).

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Huntersville?

Yes, this clinical trial (NCT00571389) has an active research site in Huntersville, NC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Solid Tumor, Adult Treatment Options in Huntersville, NC

If you're searching for solid tumor, adult treatment options in Huntersville, NC, this clinical trial (NCT00571389) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Huntersville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced solid tumor, adult specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all solid tumor, adult clinical trials near you to find additional studies recruiting in your area.

Solid Tumor, Adult Clinical Trial in Huntersville, NC

Expert Care in Huntersville

IRB Approved

No-Cost Care

Apply for This Huntersville Location

Why Participate?

Simple Process